Krebs Biochemicals & Industries Limited

KREBSBIO

INE268B01013

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-04-26 am EDT			5-day change	1st Jan Change
73.01 ^INR	+2.61%		+3.34%	-6.80%

Apr. 15	Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	CI
Feb. 12	Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer

October 20, 2023 at 07:10 am EDT

Krebs Biochemicals & Industries Limited announced the resignation of Rohit Taparia as Company Secretary and Compliance Officer of the Company has tendered his resignation on 14th September, 2023 and his resignation has been accepted by the Company effective from 20th October, 2023 after the closure of business hours.

Latest news about Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	Apr. 15	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	Jan. 17	CI
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	Dec. 18	MT
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	23-10-20	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	23-08-09	CI
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	23-08-09	CI
Krebs Biochemicals Trims Net Loss in Fiscal Q4	23-05-24	MT
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-24	CI
Krebs Biochemicals Names New CFO	23-02-03	MT
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	23-02-03	CI
Krebs Biochemicals & Industries Limited Approves CFO Changes	23-02-03	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	22-09-05	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-01	CI
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	22-08-01	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-23	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Krebs Biochemicals & Industries Limited announced that it has received INR 1 billion in funding from Ipca Laboratories Limited	21-12-29	CI
Krebs Biochemicals & Industries Limited Appoints Jitendra Shah as Additional Director, Non-Executive Category	21-11-09	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-09	CI
Krebs Biochemicals & Industries Limited to Consider Resignation of E J Babu as Non-Executive Director	21-11-02	CI
Krebs Biochemicals & Industries Limited announced that it expects to receive INR 1 billion in funding from Ipca Laboratories Limited	21-10-22	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-30	CI

Chart Krebs Biochemicals & Industries Limited

Duration

Period

Chart Krebs Biochemicals & Industries Limited

More charts

Company Profile

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Companyâs pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Sector

Pharmaceuticals

Calendar

2024-05-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KREBS BIOCHEMICALS & INDUSTRIES LIMITED	-6.80%	18.88M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B